We only have this paper's title and publication details.
Read it at the sourceThis research demonstrates nintedanib reduces profibrotic gene expression in skin fibrosis, suggesting a potential therapy for systemic sclerosis.
No takes yet. Share an insight, caveat, or question.
Shah et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: